跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
NAABAK EYEDROPS 4.9%
Approved
THERAPEUTIC
NAABAK EYEDROPS 4.9%
EXCELVISION (FRANCE)
🇸🇬 Health Sciences Authority
Approval Date
Mar 21, 2000
Approval ID
fea80703b6795883
Company
EXCELVISION (FRANCE)
Type
Therapeutic
Approval Details
Approval Id
fea80703b6795883
Drug Name
NAABAK EYEDROPS 4.9%
Product Name
NAABAK EYEDROPS 4.9%
Approval Number
SIN11294P
Approval Date
2000-03-21
Registrant
DCH AURIGA SINGAPORE
Licence Holder
DCH AURIGA SINGAPORE
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SOLUTION
Route Of Administration
OPHTHALMIC
Atc Code
S01GX03
Atc Item Name
spaglumic acid
Pharma Manufacturer Name
DCH AURIGA SINGAPORE
Company Detail Path
/organization/dch-auriga-singapore
Active Ingredients
N-ACETYL ASPARTYL GLUTAMIC ACID SODIUM SALT
4.9%
N-ACETYL ASPARTYL GLUTAMIC ACID SODIUM SALT
4.9%
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 21, 2000
Approval ID
fea80703b6795883
Type
Therapeutic
Back to HSA Approvals
NAABAK EYEDROPS 4.9% - HSA Drug Approval Details